What Is Your Clot Risk With Antiphospholipid Antibodies?
At a Glance
A positive antiphospholipid antibody test does not by itself mean you have APS. For people without other risk factors, the first blood clot risk is often under 1% per year, but persistent high-risk profiles, smoking, estrogen, illness, surgery, pregnancy, and immobility can raise it.
In this answer
5 sections
If you have had a positive blood test for antiphospholipid antibodies (aPL) but have never had a blood clot or specific pregnancy complications, you are currently considered “aPL-positive without clinical manifestations” (often called an asymptomatic carrier). There is no single risk percentage that applies to everyone. For people without other systemic autoimmune diseases or additional risk factors, the risk of a first clot is often estimated to be less than 1% per year based on observational studies [1]. However, for those with high-risk antibody profiles, the annual risk is higher [2][3].
When to Seek Emergency Care
Because you have a higher risk of developing a blood clot, it is critical to know the warning signs. Do not wait for a routine doctor’s appointment if you experience any of the following. Seek emergency medical care immediately:
- Signs of a blood clot in the leg (DVT): New, one-sided swelling, pain, warmth, or redness in your leg or arm.
- Signs of a blood clot in the lung (Pulmonary Embolism): Sudden shortness of breath, unexplained chest pain (especially when breathing deeply), coughing up blood, fainting, or a very rapid heartbeat.
- Signs of an arterial clot or stroke: Sudden weakness or numbness in your face, arm, or leg (especially on one side), sudden facial droop, trouble speaking or understanding speech, or sudden vision loss.
Note: While clots often happen after a temporary “trigger” like surgery, they can occur without any obvious cause. Never ignore these symptoms.
Carrier Status vs. Clinical APS
Having antiphospholipid antibodies circulating in your blood is not the same as having Antiphospholipid Syndrome (APS).
- Persistence is required: A single positive test does not mean you are a carrier. Temporary infections can cause antibody levels to rise. To confirm carrier status, antibodies must remain positive on a second test taken at least 12 weeks after the first [4][2].
- A clinical event is required for APS: APS is a clinical diagnosis. It requires persistent antibodies plus an objectively confirmed clinical event (a blood clot or specific pregnancy complications) [4]. Even if you develop a clot, it requires clinical assessment by a doctor to determine if it is officially APS.
The Antibody Profile: What Increases Your Risk?
Your doctor will look at your specific lab results to determine your risk level. Not all positive tests mean the same thing.
| Risk Factor | What It Means |
|---|---|
| Lupus Anticoagulant (LA) | A confusing name: It does not mean you have lupus, and despite the word “anticoagulant” (which usually means blood thinner), testing positive for LA actually indicates a higher risk of clotting [5]. |
| Triple Positivity | Testing persistently positive for all three types of aPL (lupus anticoagulant, anticardiolipin, and anti-beta-2 glycoprotein I). This is considered a major independent risk factor for a future clot [2][6]. |
| High Antibody Levels | Generally, moderate to high levels (titers) of antibodies pose a greater risk than low levels [5]. However, a high number alone does not predict your exact future, as the exact threshold depends on the specific laboratory test used. |
The “Second Hit”: Triggers and Additional Risk Factors
Antiphospholipid antibodies can act as a “first hit,” priming the body for a clot. Often, a clot happens when there is a “second hit”—an additional risk factor or temporary trigger [7].
Health and Lifestyle Factors
- Cardiovascular Risks: Smoking and high blood pressure significantly increase your risk of a clot, particularly arterial clots (like strokes) [3][8]. High cholesterol and obesity also contribute to vascular damage [9].
- Other Medical Conditions: Having systemic lupus erythematosus (SLE) can elevate your risk [8].
- Thrombocytopenia (Low Platelets): Some people with aPL have low blood platelets [3]. While this can be a marker of a higher-risk disease profile, severely low platelets also increase your risk of bleeding. This makes the decision to use aspirin or blood thinners much more complicated and requires careful medical review.
- Estrogen Exposure: Birth control methods containing estrogen (like combination pills, patches, and rings) are generally avoided because estrogen promotes blood clotting [10][11]. Do not stop taking prescribed hormones without talking to your doctor first.
Temporary Triggers
Certain situations temporarily spike your risk of developing a venous clot (like a DVT) [7][12]:
- Surgery or major trauma
- Prolonged immobilization (such as being on bed rest or taking a very long flight)
- Hospitalization for serious illness or infection
- Pregnancy and the postpartum (after giving birth) period
A Note on Family History
Because this guide focuses on familial antiphospholipid syndrome, you may be wondering about your relatives. While aPL positivity can cluster in families, it is not passed down as a simple genetic disease. Family members do not automatically need to be tested for antibodies unless they have symptoms, a history of clots, or a doctor specifically recommends it.
Primary Prevention: Protecting Yourself
Because the risk varies so much, there is no one-size-fits-all approach. Full-dose blood thinners (anticoagulation) are generally not prescribed automatically for asymptomatic carriers, because the risk of severe bleeding often outweighs the risk of a clot [13].
- Low-Dose Aspirin: For carriers with a high-risk antibody profile, guidelines often suggest considering daily low-dose aspirin [14]. Do not start taking aspirin on your own. It can cause gastrointestinal bleeding, interact with other medications, and is dangerous if you have low platelets or a history of ulcers. Always discuss the risks and benefits with your doctor [1].
- Manage Lifestyle Risks: Quitting smoking, maintaining a healthy weight, and controlling blood pressure and cholesterol are highly effective ways to lower your baseline risk [14][9].
- Temporary Protection: During high-risk periods (like surgery or pregnancy), your doctor may prescribe temporary, preventative doses of blood thinners (like heparin injections) to protect you [15][13]. Pre-pregnancy planning is crucial so this plan is in place before you conceive.
- Contraception Options: Discuss alternatives to estrogen with your gynecologist. Non-hormonal copper intrauterine devices (IUDs) and certain progestin-only options (like the levonorgestrel IUD) are often considered safer alternatives [16][11].
Common questions in this guide
Does a positive antiphospholipid antibody test mean I have APS?
How likely am I to have a first clot if I have aPL but no APS history?
Which antiphospholipid antibody results are considered high risk?
Should I take aspirin or a blood thinner if I have antibodies but have never had a clot?
What can trigger a blood clot when I have antiphospholipid antibodies?
What symptoms mean I need emergency help for a clot or stroke?
Can I use estrogen-containing birth control if I have antiphospholipid antibodies?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my lab results, do I have a low, moderate, or high-risk antibody profile, and have they been persistently positive for over 12 weeks?
- 2.Given my personal bleeding risk, platelet count, and antibody profile, do you recommend I take daily low-dose aspirin?
- 3.What is our specific plan for temporary preventative blood thinners if I need surgery, become pregnant, or have to travel long distances?
- 4.Do I need to see a hematologist or rheumatologist for long-term follow-up?
- 5.Are there any specific non-estrogen birth control methods you recommend for my situation?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (16)
- 1
Primary Thrombosis Prophylaxis in Persistently Antiphospholipid Antibody-Positive Individuals: Where Do We Stand in 2018?
Zuo Y, Barbhaiya M, Erkan D
Current rheumatology reports 2018; (20(11)):66 doi:10.1007/s11926-018-0775-8.
PMID: 30203272 - 2
Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity.
Yelnik CM, Urbanski G, Drumez E, et al.
Lupus 2017; (26(2)):163-169 doi:10.1177/0961203316657433.
PMID: 27432808 - 3
Risk Factors for the Development of the Disease in Antiphospholipid Antibodies Carriers: A Long-term Follow-up Study.
Pablo RD, Cacho PM, López-Hoyos M, et al.
Clinical reviews in allergy & immunology 2022; (62(2)):354-362 doi:10.1007/s12016-021-08862-5.
PMID: 34216367 - 4
Antiphospholipid antibodies are persistently positive at high titers. Additive value of platelet-bound C4d.
Sciascia S, Bloch R, O'Malley T, et al.
Frontiers in immunology 2022; (13()):949919 doi:10.3389/fimmu.2022.949919.
PMID: 36032074 - 5
Risk Assessment and Antithrombotic Strategies in Antiphospholipid Antibody Carriers.
Calcaterra I, Ambrosino P, Vitelli N, et al.
Biomedicines 2021; (9(2)) doi:10.3390/biomedicines9020122.
PMID: 33513790 - 6
IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers.
Tonello M, Mattia E, Favaro M, et al.
Thrombosis research 2019; (177()):157-160 doi:10.1016/j.thromres.2019.03.006.
PMID: 30903876 - 7
Antiphospholipid antibodies and cardiovascular thrombosis.
Rashedi S, Leyva H, Siddiqui SA, et al.
Nature reviews. Cardiology 2026; (23(10)):741-756 doi:10.1038/s41569-026-01269-9.
PMID: 41807758 - 8
Additional risk factors associated with thrombosis and pregnancy morbidity in a unique cohort of antiphospholipid antibody-positive patients.
Li C, Zuo Y, Zhang S, et al.
Chinese medical journal 2022; (135(6)):658-664 doi:10.1097/CM9.0000000000001964.
PMID: 35143425 - 9
Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis.
Tektonidou MG
Journal of autoimmunity 2022; (128()):102813 doi:10.1016/j.jaut.2022.102813.
PMID: 35247655 - 10
Contraceptive Care in the Rheumatic Diseases: A Review.
Luche N, Talabi MB
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2024; (30(7S Suppl 1)):S5-S12 doi:10.1097/RHU.0000000000002124.
PMID: 39325120 - 11
Contraception in systemic lupus erythematosus and antiphospholipid antibody syndrome.
He L, Marder W
Current opinion in rheumatology 2026; (38(4)):297-303 doi:10.1097/BOR.0000000000001162.
PMID: 42046526 - 12
Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Syndrome.
Aguirre Del-Pino R, Monahan RC, Huizinga TWJ, et al.
Seminars in thrombosis and hemostasis 2024; (50(6)):817-828 doi:10.1055/s-0043-1776910.
PMID: 38228166 - 13
The antiphospholipid syndrome in patients with systemic lupus erythematosus.
Pons-Estel GJ, Andreoli L, Scanzi F, et al.
Journal of autoimmunity 2017; (76()):10-20 doi:10.1016/j.jaut.2016.10.004.
PMID: 27776934 - 14
EULAR recommendations for the management of antiphospholipid syndrome in adults.
Tektonidou MG, Andreoli L, Limper M, et al.
Annals of the rheumatic diseases 2019; (78(10)):1296-1304 doi:10.1136/annrheumdis-2019-215213.
PMID: 31092409 - 15
Primary thromboprophylaxis with low-dose aspirin and antiphospholipid antibodies: Pro's and Con's.
Arnaud L, Conti F, Massaro L, et al.
Autoimmunity reviews 2017; (16(11)):1103-1108 doi:10.1016/j.autrev.2017.09.003.
PMID: 28911988 - 16
Which Hormones and Contraception for Women with APS? Exogenous Hormone Use in Women with APS.
Sammaritano LR
Current rheumatology reports 2021; (23(6)):44 doi:10.1007/s11926-021-01006-w.
PMID: 33939022
This page explains blood-clot risk for people with antiphospholipid antibodies for educational purposes only and does not replace medical advice. Your clinician should interpret your antibody profile and decide whether aspirin, preventive anticoagulation, or contraceptive changes are appropriate.
Get notified when new evidence is published on familial antiphospholipid syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.